Lorillard Hires FDA Official to Tackle Tobacco Regulation

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Lorillard (NYSE: LO  ) has hired one of the U.S. Food and Drug Administration's own to help the tobacco giant comply with federal tobacco regulation.

Neil Wilcox, a former FDA science policy analyst, has been named Lorillard's senior vice president and chief compliance officer, a new position for the Greensboro, North Carolina-based company. Lorillard is the third-largest cigarette manufacturer in the United States and the market leader in menthol cigarettes with an estimated 35 percent market share.

Lorillard said that Wilcox will oversee and manage regulatory affairs that include compliance with the federal Family Smoking Prevention and Tobacco Control Act. The hire of Wilcox comes as menthol cigarettes are expected to come under stricter FDA scrutiny. An FDA panel in March recommended a banning of all menthol cigarettes and said in part that removing menthol cigarettes from the marketplace "would benefit public health in the United States."

The panel's recommendation is advisory and the agency is under no obligation to formally adopt recommendations. But even if the FDA doesn't ban menthol outright, it could impose stricter rules on the cigarette flavoring. The FDA was expected to comment on the panel's findings in 90 days, which means the agency could say something on the matter sometime this month.

Wilcox spent 13 years as a science and regulatory expert at the FDA, most recently as science policy analyst in the Center for Food Safety and Applied Nutrition. He has also worked at The Gillette Company as director of global regulatory affairs and as vice president of global regulatory and scientific affairs at the Kimberly Clark Corporation (NYSE: KMB  ) . Lorillard said that at both companies he developed and implemented plans to achieve global regulatory compliance for a variety of products.

Motley Fool newsletter services have recommended buying shares of Kimberly-Clark. Motley Fool newsletter services have recommended writing puts in Lorillard. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1504743, ~/Articles/ArticleHandler.aspx, 10/25/2016 7:16:44 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

6/12/2015 4:05 PM
LO.DL $0.00 Down +0.00 +0.00%
Lorillard CAPS Rating: ****
KMB $113.73 Down -0.18 -0.16%
Kimberly-Clark CAPS Rating: ****